Technological aid by advanced microfluidics, digital optics, lab-on-a-chip experiments, and devices is expected to further enhance the quality of POCT. Backed by such factors the market for global POCT is expected to grow at a CAGR of around 8.4% during 2013-2018 to reach a value of US$ 24 Billion by 2018. According to “Global Point-of-Care Diagnostics Market Outlook 2018”, the global POCT industry is at a very crucial stage with POCT expanding itself into diverse disease areas, such as cancer and HIV diagnostics. The coming years will witness POCT take over routine diagnostics, as the focus shifts from curative to preventive care with enhanced patient involvement.
Currently, the United States accounts for almost 50% of the total POCT market, followed by regions, such as Europe and Japan. In these developed regions, the proliferation of transportable, portable and handheld instruments along with ever-increasing incidence of lifestyle related disorders, such as diabetes has supported the growth of Point of Care testing. At the same time, rapid advancements in technology and infrastructure and the availability of diagnostic systems that cannot be employed in resource limited settings will result in enhanced uptake of POCT in emerging nations.
The report provides a brief outlook of the IVD industry, covering major aspects, such as current market size, future growth and current and future geographical segmentation. It also talks about the major players of IVD industry and their respective contribution to the current market. Next, we have covered the POCT industry in depth, estimating the current and future market and tracking the recent developments that have taken place. A geographical segmentation of the POCT market is next in line with current estimates and future forecasts for major geographies. In every region, an opportunity assessment based on disease demographics for POCT players has been done.
The report also discusses trends that are a part of the global POCT industry, including the likes of the growing role of POCT in diagnosis of HIV and non-communicable diseases, such as Cancer. At the end, major players of the industry have been highlighted and thorough profiling has been carried out to present POCT product portfolios, business segmentations, strengths and weakness, and recent developments of every player.
And More Visit:- http://www.rncos.com/